Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes.

[1]  L. Rodella,et al.  Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. , 2005, American journal of physiology. Heart and circulatory physiology.

[2]  N. Abraham,et al.  D-4F Induces Heme Oxygenase-1 and Extracellular Superoxide Dismutase, Decreases Endothelial Cell Sloughing, and Improves Vascular Reactivity in Rat Model of Diabetes , 2005, Circulation.

[3]  G. Li Volti,et al.  Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: linking heme to hyperglycemia complications. , 2005, Current neurovascular research.

[4]  Xin-Yuan Fu,et al.  Carbon Monoxide Differentially Modulates STAT1 and STAT3 and Inhibits Apoptosis via a Phosphatidylinositol 3-Kinase/Akt and p38 Kinase-dependent STAT3 Pathway during Anoxia-Reoxygenation Injury* , 2005, Journal of Biological Chemistry.

[5]  S. Cuzzocrea,et al.  Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. , 2005, Diabetes.

[6]  M. Layne,et al.  Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. , 2005, Diabetes.

[7]  N. Abraham,et al.  Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c , 2005, Diabetologia.

[8]  L. Rodella,et al.  Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. , 2004, American journal of physiology. Heart and circulatory physiology.

[9]  S. Solomon,et al.  Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Ogier-Denis,et al.  Induction of Heme Oxygenase-1 Inhibits NAD(P)H Oxidase Activity by Down-regulating Cytochrome b558 Expression via the Reduction of Heme Availability* , 2004, Journal of Biological Chemistry.

[11]  K. Takeda,et al.  Transient glucose deprivation causes upregulation of heme oxygenase-1 and cyclooxygenase-2 expression in cardiac fibroblasts. , 2004, Journal of molecular and cellular cardiology.

[12]  N. Abraham,et al.  Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. , 2004, Kidney international.

[13]  R. Bolli,et al.  Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. , 2004, American journal of physiology. Heart and circulatory physiology.

[14]  F. Bach,et al.  Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Y. Tang,et al.  Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid System , 2004, Hypertension.

[16]  N. Abraham,et al.  Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. , 2004, Biochemical and biophysical research communications.

[17]  C. Graham,et al.  Effect of glucose and oxygen deprivation on heme oxygenase expression in human chorionic villi explants and immortalized trophoblast cells. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  Z. Darżynkiewicz,et al.  Heme Oxygenase-1 Attenuates Glucose-Mediated Cell Growth Arrest and Apoptosis in Human Microvessel Endothelial Cells , 2003, Circulation research.

[19]  M. Febbraio,et al.  Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. , 2003, Diabetes.

[20]  M. Suematsu,et al.  Bilirubin rinse: A simple protectant against the rat liver graft injury mimicking heme oxygenase–1 preconditioning , 2003, Hepatology.

[21]  F. Bach,et al.  Biliverdin protects rat livers from ischemia/reperfusion injury. , 2003, Transplantation proceedings.

[22]  R. Foresti,et al.  Metal carbonyls: a new class of pharmaceuticals? , 2003, Angewandte Chemie.

[23]  M. Haubitz,et al.  Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis , 2003, The Lancet.

[24]  F. Bach,et al.  Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. , 2001, Diabetes.

[25]  J. Ingwall,et al.  Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.

[26]  D. Levy,et al.  Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. , 2001, The American journal of cardiology.

[27]  Fan Zhang,et al.  Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. , 2001, The Journal of clinical investigation.

[28]  J. Alam,et al.  The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. , 2000, The American journal of pathology.

[29]  L. Myatt,et al.  Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. , 2000, American journal of physiology. Heart and circulatory physiology.

[30]  K. Matsumoto,et al.  Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. , 1999, Circulation research.

[31]  S. Milstien,et al.  Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. , 1999, Biochemical and biophysical research communications.

[32]  Xueliang Du,et al.  Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? , 1999 .

[33]  N. Abraham,et al.  Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. , 1999, The Journal of pharmacology and experimental therapeutics.

[34]  L. Horwitz,et al.  A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. , 1999 .

[35]  T. Lüscher,et al.  Atherosclerosis and the two faces of endothelial nitric oxide synthase. , 1998, Circulation.

[36]  S. Tonegawa,et al.  Reduced stress defense in heme oxygenase 1-deficient cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Lusis,et al.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.

[38]  S. Shibahara,et al.  Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. , 1997, Current eye research.

[39]  M. Goligorsky,et al.  Dual role of heme oxygenase in epithelial cell injury: contrasting effects of short-term and long-term exposure to oxidant stress. , 1996, The Journal of laboratory and clinical medicine.

[40]  M. Gerritsen,et al.  Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Gallop,et al.  An NADPH oxidase superoxide-generating system in the rabbit aorta. , 1995, The American journal of physiology.

[42]  G. Vercellotti,et al.  Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo. , 1995, Kidney international.

[43]  A. Ceriello,et al.  Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanisms of diabetic vascular complications , 1992, In Vitro Cellular & Developmental Biology - Animal.

[44]  K. Takeshige,et al.  Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. , 1991, Biochimica et biophysica acta.

[45]  B. Ames,et al.  Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Sano,et al.  Mode of Inhibitory Action of Bilirubin on Protein Kinase C , 1985, Pediatric Research.

[47]  R. Cohen,et al.  High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. , 2002, Diabetes.

[48]  Y. Oda,et al.  Heme oxygenase-1 deficiency: the first autopsy case. , 2002, Human pathology.

[49]  N. Abraham,et al.  Role of human heme oxygenase‐1 in attenuating TNF‐α‐mediated inflammation injury in endothelial cells , 2002, Journal of cellular biochemistry.

[50]  Y. Niida,et al.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.